{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:32:31Z","timestamp":1793971951824,"version":"4.8.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023296","name":"Alliance Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.esmoop.2026.106305","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:18:33Z","timestamp":1773173913000},"page":"106305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Somatic and germline genomic variation in thymic carcinomas"],"prefix":"10.1016","volume":"11","author":[{"given":"F.","family":"Tettamanzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-8307","authenticated-orcid":false,"given":"C.","family":"De Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-2967","authenticated-orcid":false,"given":"C.","family":"Cappadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-4125","authenticated-orcid":false,"given":"D.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rimoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Piombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4362-9892","authenticated-orcid":false,"given":"L.G.","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-2905","authenticated-orcid":false,"given":"S.","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-6797","authenticated-orcid":false,"given":"E.","family":"Voulaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1783-7651","authenticated-orcid":false,"given":"S.","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-4728","authenticated-orcid":false,"given":"L.","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-1702","authenticated-orcid":false,"given":"P.A.","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-0619","authenticated-orcid":false,"given":"R.","family":"Asselta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2026.106305_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl 5","key":"10.1016\/j.esmoop.2026.106305_bib3","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","article-title":"Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Girard","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.106305_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/med-21-11","article-title":"Systemic treatments for thymic tumors: a narrative review","volume":"5","author":"Zucali","year":"2021","journal-title":"Mediastinum"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J Clinl Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.106305_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106305_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.106305_bib11","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.esmoop.2026.106305_bib13","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1038\/cddis.2012.92","article-title":"Copy number aberrations of BCL2 and CDKN2A\/B identified by array-CGH in thymic epithelial tumors","volume":"3","author":"Petrini","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.esmoop.2026.106305_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2021.05.029","article-title":"Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy","volume":"153","author":"Repetto","year":"2021","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.106305_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2019.11.013","article-title":"The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: the impact of the eighth edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors","volume":"15","author":"Ruffini","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106305_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.CIR.0000051465.94572.D0","article-title":"No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age","volume":"107","author":"Mannucci","year":"2003","journal-title":"Circulation"},{"issue":"7537","key":"10.1016\/j.esmoop.2026.106305_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106305_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"issue":"14","key":"10.1016\/j.esmoop.2026.106305_bib21","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106305_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.esmoop.2026.106305_bib23","article-title":"Calling somatic SNVs and indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106305_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106305_bib25","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkw227","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.esmoop.2026.106305_bib26","article-title":"Scaling accurate genetic variant discovery to tens of thousands of samples","author":"Poplin","year":"2017","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume":"10","author":"Tamborero","year":"2018","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gpb.2020.02.001","article-title":"MSIsensor-pro: fast, accurate, and matched-normal-sample-free detection of microsatellite instability","volume":"18","author":"Jia","year":"2020","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","article-title":"PureCN: copy number calling and SNV classification using targeted short read sequencing","volume":"11","author":"Riester","year":"2016","journal-title":"Source Code Biol Med"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib33","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-018-0539-0","article-title":"MutationalPatterns: comprehensive genome-wide analysis of mutational processes","volume":"10","author":"Blokzijl","year":"2018","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12864-019-6041-2","article-title":"SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events","volume":"20","author":"Bergstrom","year":"2019","journal-title":"BMC Genomics"},{"issue":"D1","key":"10.1016\/j.esmoop.2026.106305_bib36","doi-asserted-by":"crossref","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","article-title":"COSMIC: a curated database of somatic variants and clinical data for cancer","volume":"52","author":"Sondka","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods","volume":"1","author":"Wilcoxon","year":"1945","journal-title":"Biometrics Bull"},{"issue":"282","key":"10.1016\/j.esmoop.2026.106305_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.esmoop.2026.106305_bib41","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B (Methodol)"},{"issue":"D1","key":"10.1016\/j.esmoop.2026.106305_bib44","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.esmoop.2026.106305_bib45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/oncolo\/oyac115","article-title":"Comprehensive genomic profiling of 274 thymic epithelial tumors unveils oncogenic pathways and predictive biomarkers","volume":"27","author":"Girard","year":"2022","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.esmoop.2026.106305_bib46","doi-asserted-by":"crossref","first-page":"10575","DOI":"10.1002\/cam4.5795","article-title":"Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106305_bib47","doi-asserted-by":"crossref","first-page":"101627","DOI":"10.1016\/j.esmoop.2023.101627","article-title":"Genomic characterization of thymic epithelial tumors in a real-world dataset","volume":"8","author":"Kurokawa","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2026.106305_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2020.02.001","article-title":"Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variations","volume":"476","author":"Chen","year":"2020","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106305_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1055-9965.EPI-23-1466","article-title":"Large-scale cancer genomic analysis reveals significant disparities between microsatellite instability and tumor mutational burden","volume":"33","author":"Choi","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.esmoop.2026.106305_bib50","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/cam4.1372","article-title":"Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients","volume":"7","author":"Vanderwalde","year":"2018","journal-title":"Cancer Med"},{"issue":"22","key":"10.1016\/j.esmoop.2026.106305_bib51","doi-asserted-by":"crossref","first-page":"640","DOI":"10.21037\/atm.2019.10.116","article-title":"Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"},{"issue":"10","key":"10.1016\/j.esmoop.2026.106305_bib52","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S1470-2045(22)00542-3","article-title":"Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Conforti","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2026.106305_bib53","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Guideline Thymomas and Thymic Carcinomas version 1.2024. A National Comprehensive Cancer Network, Inc","year":"2024"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100612","article-title":"Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors","volume":"6","author":"M\u00f6hrmann","year":"2025","journal-title":"Med"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106305_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13070","article-title":"Prevalence of germline findings among tumors from cancer types lacking hereditary testing guidelines","volume":"5","author":"Yap","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib56","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.esmoop.2026.106305_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.esmoop.2026.106305_bib59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","article-title":"Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study","volume":"25","author":"Sicklick","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.esmoop.2026.106305_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1634\/theoncologist.2019-0393","article-title":"Metastatic thymoma harboring a deleterious BRCA2 mutation derives durable clinical benefit from olaparib","volume":"25","author":"Principe","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.esmoop.2026.106305_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37294","article-title":"Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death","volume":"7","author":"Hieronymus","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13039-019-0429-1","article-title":"The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity","volume":"12","author":"Tijhuis","year":"2019","journal-title":"Mol Cytogenet"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106305_bib63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ng.3341","article-title":"Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer","volume":"47","author":"Childs","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13053-024-00299-z","article-title":"A genome-wide association study in Swedish colorectal cancer patients with gastric- and prostate cancer in relatives","volume":"22","author":"Samola Winnberg","year":"2024","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.esmoop.2026.106305_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-9-237","article-title":"Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung","volume":"9","author":"Kang","year":"2009","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2026.106305_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100774","article-title":"Cytogenomic and clinicopathologic comparison of MYC-positive and MYC-negative high-grade B-cell lymphoma with 11q aberration in the context of other aggressive lymphomas with MYC rearrangement","volume":"38","author":"Grygalewicz","year":"2025","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib67","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1530\/ERC-21-0083","article-title":"The role of membrane mucin MUC4 in breast cancer metastasis","volume":"29","author":"Dreyer","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib68","doi-asserted-by":"crossref","first-page":"43.e13","DOI":"10.1016\/j.urolonc.2019.09.024","article-title":"8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival","volume":"38","author":"Eichenauer","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.106305_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41467-017-00493-9","article-title":"APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.esmoop.2026.106305_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2559.2002.01413.x","article-title":"Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas","volume":"40","author":"Zudaire","year":"2002","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.esmoop.2026.106305_bib71","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/301973","article-title":"From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization","volume":"63","author":"Chen","year":"1998","journal-title":"Am J Hum Genet"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926002474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926002474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:56:09Z","timestamp":1776099369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926002474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2059702926002474"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.106305","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic and germline genomic variation in thymic carcinomas","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.106305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"106305"}}